Permethrin increased the incidence of bronchiolo-alveolar adenomas in female mice but not male mice or female or male rats. Studies were conducted to determine whether permethrin has mitogenic activity in Club cells in mouse lung as the basis for the mode of action (MOA) for the lung adenoma induction. Several short-term experiments focusing on timecourse, dose-response, reversibility, sex difference, strain difference, and species difference were evaluated for Club cell proliferation and morphology. The findings demonstrated that permethrin slightly and continuously enhanced Club cell proliferation at tumor-associated dose levels in female mice, but did not increase proliferation in male mice or in female rats. Electron microscopic examination demonstrated that permethrin produced morphological alterations in Club cells prior to increasing the Club cell proliferation. There was no evidence of increased cell death. These alterations in Club cells were also observed with a close structural analog cypermethrin. Taken together, the present studies provide evidence that the MOA for induction of mouse lung adenomas by permethrin involves slight morphological effects on Club cells, sustained Club cell proliferation, and eventually hyperplasia and bronchiolo-alveolar adenoma in susceptible mice. The potential human carcinogenic hazard of permethrin based on the tumorigenic MOA for lung tumors in mice was evaluated using the International Programme on Chemical Safety Human Relevance Framework. As humans are quantitatively much less sensitive to agents that increase Club cell proliferation and tumor formation in mice, it is not likely permethrin will lead to an increase in susceptibility to lung tumor development in humans. Epidemiological data for permethrin strongly supports this conclusion.
transportation, structures, buildings, Public Health Mosquito abatement programs, numerous indoor and outdoor residential spaces, pets, and clothing (US.EPA, 2009).
As a part of the hazard assessment of permethrin, a 2-year carcinogenicity study was performed in male and female Charles River CD-1 mice: dietary dose levels of permethrin were 0 (control), 20, 500, and 2000 ppm for males, and 0, 20, 2500, and 5000 ppm for females (unpublished data refereed to US. EPA, 2002) . As shown in Table 1 , a Pathology Working Group (PWG) report indicated that permethrin increased lung adenomas at 2500 and 5000 ppm in female mice, but did not increase the incidence of lung adenomas in male mice or the incidence of lung carcinomas in both sexes (CA.EPA, 1994) . The Cancer Assessment Review Committee of US.EPA/Office of Pesticide Programs/Health Effects Division also confirmed a previous Carcinogenicity Peer Review Committee Report that there were statistically significant increases in liver adenomas in male mice at all permethrin dose levels and in female mice given 2500 and 5000 ppm permethrin. However, treatment with permethrin did not result in any significant increase in hepatocellular carcinoma in either male or female mice. The combined incidence of hepatocellular adenoma and carcinoma was significantly increased in male mice given 500 ppm permethrin and female mice given 2500 and 5000 ppm permethrin. Based on the findings from these studies, the US.EPA concluded that tumorigenicity of permethrin was seen in the lung of CD-1 female mice (at 2500 and 5000 ppm) and the liver of both male and female CD-1 mice (at 20, 500, and 2000 ppm for male, and 2500 and 5000 ppm for female) (US. EPA, 2002) . This article focuses on permethrin-induced mouse lung tumor formation, the evaluation of liver tumor formation will be considered elsewhere (in preparation).
Theoretically the mode of action (MOA) could be by a genotoxic mechanism or by a nongenotoxic mechanism such as cytotoxicity (possibly related to oxidative damage), direct mitogenicity or immunosuppression (Strupp et al., 2016) . Increased cell proliferation is an essential step in carcinogenesis by nongenotoxic chemicals (Cohen and Arnold, 2011) . Club cells (formerly Clara cells) are usually the target for lung carcinogenesis in mice (Born et al., 1998; Cruzan et al., 2009 Cruzan et al., , 2012 Cruzan et al., , 2015 Foster et al., 1992 Foster et al., , 1994 Green, 2000; Green et al., 1997 Green et al., , 2001b IARC, 1987; Strupp et al., 2012 Strupp et al., , 2016 US.EPA, 2005) . These studies were conducted to evaluate direct mitogenic activity of Club cells in mouse lung as the MOA for mouse lung tumor induction by permethrin. To determine the effects of permethrin on lung Club cell proliferation, several experiments focusing on time-course, dose-response, reversibility, sex difference, strain difference, and species difference were conducted. 5-Bromo-2 0 -deoxyuridine (BrdU) labeling index was used to evaluate the proliferation of the S-phase activity of the cell cycle as a marker of DNA synthesis in the present studies (Wood et al., 2015) . Alternative MOAs were also evaluated. Recently developed genomics technology has the potential to improve our understanding of an organism's response to stressors, and there is general agreement that toxicogenomics will play an increasing role in regulatory decision-making (Boverhof and Zacharewski, 2006) . As part of a series of analyses of the MOA of mouse lung tumors by permethrin, the global gene expression profile in the lung at an early phase (after 7-and 14-day treatment) was evaluated using DNA microarray and gene ontology (GO) analysis.
Based on the data obtained in these studies and existing data in previous studies, the postulated MOA for permethrininduced mouse lung tumors was analyzed followed by an analysis of the human relevance of the postulated MOA according to the International Programme on Chemical Safety (IPCS) framework (Boobis et al., 2006 (Boobis et al., , 2008 Cohen et al., 2004; Meek et al., 2003; Sonich-Mullin et al., 2001) . 
MATERIALS AND METHODS

Chemicals
Data represent the number of animals with the lesion/total number of mice examined. The numbers in parentheses represent the percentage incidence. The tumor incidences in Table 1 are based on a second reading of slides by a pathologist contracted by the US.EPA (CA.EPA, 1994) , with the exception of the female lung tumor incidences which are derived from the findings of the PWG (US. EPA, 2002) . The shaded areas present statistically significant (not necessarily toxicologically significant) changes.
Significantly different from the control group (0 ppm) (* P < .05; ** P < .01).
cold storage) were provided by Sumitomo Chemical Co., Ltd.
(Osaka, Japan); isoniazid (lot No. 029K1526; purity >99.0%; storage condition, room temperature) was purchased from Sigma Aldrich (St Louis, Missouri, USA).
Animals and Husbandry
All experiments were performed in accordance with The Guide for Animal Care and Use of Sumitomo Chemical Co., Ltd. Crlj:CD1(ICR) mice (purchased from Charles River Japan, Inc., Hino Breeding Center, Shiga, Japan) were primarily used in these studies. The Crlj:CD1(ICR) mouse strain was selected as the test animal for 2 reasons: CD-1 mouse is the species and strain used in the oncogenicity study of permethrin (US. EPA, 2002) , and its genetic and microbiological properties are known. In addition to Crlj:CD1(ICR) mice, female BALB/cAnN and C57BL/6N mice (purchased from Charles River Japan, Inc., Hino Breeding Center), and female viable yellow agouti mouse (Avy) on a C57BL/6J background (originally obtained from the colony at Duke University Medical Center, and then maintained in our laboratory) and C57BL/6J were used for evaluation of strain differences with different susceptibility for lung tumor development. BALB/c and C57BL are relatively susceptible and resistant strains, respectively, for development of lung tumors (Manenti et al., 2003; Shimkin and Stoner, 1975) . The Avy mouse is known to be susceptible to lung tumor formation by linden treatment (Wolff et al., 1987; Yen et al., 1994) .
HarlanRccHanTM:WIST rats (purchased from Japan Laboratory Animals, Inc., Hanno Breeding Center, Saitama, Japan) were also used for evaluation of possible species difference. Wistar rat was selected as the test strain for 2 reasons: Wistar rat is the species and strain used in the oncogenicity study of permethrin (US. EPA, 2002) , and its genetic and microbiological properties are known.
The animals were acclimated to laboratory conditions for 7 days prior to dosing (at the commencement of dosing, the age of animals was 10 weeks). The animals were housed in a barrier-system animal room. During the course of the study, the environmental conditions in the animal room were targeted within a temperature range of 22 C -26 C and a relative humidity range of 40%-70%, with frequent ventilation (more than 10 times per hour) and a 12-h light (8:00-20:00)/12-h dark (20:00-8:00) illumination cycle. Animals were housed 1 or 2 per cage in suspended aluminum cages with stainless steel wire-mesh front and floor (Yamato Scientific Co., Ltd., Tokyo, Japan). A commercially available pulverized diet (CRF-1; Oriental Yeast Co., Ltd., Tokyo) and filtered tap water were provided ad libitum throughout the studies. The animals were not fasted overnight prior to sacrifice.
Study Design
Summary of study design of each experiment is shown in Supplementary Table 1 .
Experiment 1a, time-course. Female Crlj:CD1(ICR) mice (10 weeks of age, 6 mice/dose) were fed diets containing 0 (control) or 5000 ppm permethrin for 3, 7, 14, or 28 days. As shown in Table 1 in the previous 2-year bioassay, lung tumors were increased at dietary concentrations of 2500 and 5000 ppm but not 20 ppm (US. EPA, 2002) . To keep the size of the experimental practical given limited manpower, 1 dose group (5000 ppm, the highest tumor-inducing dose level in females in the mouse bioassay, Table 1 ) was selected for this experiment. In addition, as a positive control, another group was fed diet containing isoniazid 2500 ppm, equivalent to the lung carcinogenic dose level in a 7-month feeding study (Mori et al., 1960) . Mortality, body weights, food consumption, lung weight, gross pathology, lung histopathology (light and electron microscopy), and Club cell proliferation (BrdU immunohistochemical labeling index and Ki-67 mRNA expression analyses) were examined. As shown in the "Results" Section (Table 2) , experiment 1a showed significantly increased BrdU labeling at days 14 and 28 but not at day 7, with relatively large variations. To reduce possible confounding in intraperitoneal injection of BrdU (low positive rate), a minipump method was used in further studies to enhance evaluation of the BrdU labeling index.
Experiment 1b, time-course. Female Crlj:CD1(ICR) mice (10 weeks of age, 10 mice/dose) were fed diets containing 0 (control), 5000, or 10 000 ppm permethrin for 7 or 14 days. As mentioned above, 5000 ppm is the highest lung tumor-inducing dose (2500 and 5000 ppm, Table 1 ) in the 2-year bioassay (US. EPA, 2002) . To enhance detection of permethrin effects, twice the highest dose level in the 2-year bioassay, 10 000ppm, was also used in this MOA experiment. In addition, isoniazid 2500 ppm was used as a positive control as described in experiment 1a. Mortality, body weights, food consumption, gross pathology, lung histopathology (light and electron microscopy), Club cell proliferation (BrdU labeling index), and gene expression profiling were examined. Since lung weight was not altered by permethrin treatment up to 28 days (Table 2) , this endpoint was not determined in further experiments. For gene expression analysis, 5 animals per group were analyzed in the present experiment. To determine molecular mechanisms for enhancement of Club cell proliferation by permethrin or isoniazid in the treated groups, the 5 animals with the highest BrdU labeling indices were selected, enhancing detection of alterations of proliferation-related genes by permethrin treatment. In the control group, 5 animals showing BrdU labeling indices close to the group mean value were selected to serve as expected normal values. In addition, since CYP2F2 and CYP2E1 are known to contribute to some chemically-induced mouse lung tumorigenesis (Cruzan et al., 2009; Ghanayem, 2007; Strupp et al., 2016) , the effect of permethrin on Cyp2f2 and Cyp2e1mRNA levels in the lung of female mice (n ¼ 10) was determined.
Experiment 2, dose-response, reversibility, and sex difference. Both sexes of Crlj:CD1(ICR) mice (10 weeks of age, 12 mice/dose) were fed diets containing 0 (control), 20, 500, 2500, or 5000 ppm permethrin for males, and 0, 20, 500, 2500, 5000, or 10 000 ppm permethrin for females for a period of 7 days. In addition, to examine reversibility of alterations by permethrin, the highest dose groups of both sexes had an additional 12 mice which were dosed for 7 days followed by 34 (females) or 35 (males) days with untreated diet. Mortality, body weights, food consumption, gross pathology, lung histopathology (light and electron microscopy), and Club cell proliferation (BrdU labeling index) were examined.
Experiment 3 acute cytotoxicity. Female Crlj:CD1(ICR) mice (10 weeks of age, 6 mice/dose) were fed diets containing 0 (control), 5000, or 10 000 ppm for 1 day (approximately 24 h); and for the dosing study by oral gavage, permethrin was administered to female mice at 150 mg/kg with corn oil as the vehicle. In addition, as positive controls for lung tumor induction, isoniazid (1000 ppm in diet) (Mori et al., 1960) and coumarin (a selective Club cell cytotoxic agent, 150 and 200 mg/kg by oral gavage) (Born et al., 1998) were administered to additional mice in the same manner. Mortality, body weight, body weight gain, food The number of animals with findings/the number of animals examined.
Significantly different from the control group (*P < .05; **P < .01).
consumption, gross pathology, and lung histopathology (light and electoron microscopy) were determined.
Experiment 4a, strain difference. Female BALB/cAnN and C57BL/6N mice (10 weeks of age, 10 mice/dose) were fed diets containing 0 (control) or 10 000 ppm permethrin for a period of 7 days. Mortality, body weights, food consumption, gross pathology, and Club cell proliferation (BrdU labeling index) were examined.
Experiment 4b, strain difference. Female Avy and C57BL/6J mice (10 weeks of age, 10 mice/dose) were fed diets containing 0 (control) or 10 000 ppm permethrin for a period of 7 days. Mortality, body weights, food consumption, gross pathology, and Club cell proliferation (BrdU labeling index) were examined.
Experiment 5, species difference. Female HarlanRccHanTM:WIST rats (10 weeks of age, 10 rats/dose) were fed diets containing 0 (control) or 2500 ppm permethrin for 7 days. In the 2-year feeding study in rats (concentrations, 0, 500, 1000, and 2500 ppm) (US. EPA, 2002) , 2500 ppm was the highest dose, which was the maximum tolerated dose. According to the Joint FAO/WHO Meeting on Pesticide Residues (JMPR), treatment with permethrin at 5000 ppm or 10000 ppm resulted in death in 60% to 100% of rats, respectively (JMPR, 1999) . Therefore, 2500 ppm is sufficient to determine whether permethrin affects rat lung or not. Mortality, body weights, food consumption, gross pathology, lung histopathology (electron microscopy), and Club cell proliferation (BrdU labeling index) were examined. In rats, Club cells are significantly fewer in number than in mice, particularly in the terminal bronchiolar region (Green et al., 2001b) . Therefore, BrdU labeling index was evaluated in bronchiolo-alveolar epithelial cells.
Experiment 6, comparison with cypermethrin. Female Crlj:CD1(ICR) mice (10 weeks of age, 10 mice/dose) were fed diets containing 0 (control), 1600, or 2100 ppm cypermethrin for periods of 7 and 14 days. In addition, other groups were fed diets by the same study protocol containing isoniazid at 600 and 1000 ppm as positive control for lung tumor induction. In the mouse carcinogenicity study with cypermethrin (concentrations of 0, 100, 400, and 1600 ppm) (US. EPA, 2003) , the incidence of lung adenomas in females was higher at the dietary concentration of 1600 ppm but not at 100 or 400 ppm compared with the control. Thus, 1600 and 2100 ppm, the highest dose and 1.3-fold of the highest dose were selected in the present experiment to evaluate a potential mitogenic effect of cypermethrin on Club cells in mouse lung. The dietary concentration of isoniazid was changed from experiment 1a and 1b, where 2500 ppm was used, due to a possible confounding effect of body weight gain suppression. The dose levels were set at 600 and 1000 ppm, equivalent to dose levels at which the incidences of lung tumors in a mouse 7-month feeding study were 50 and 60%, respectively (Mori et al., 1960) . Isoniazid at dose level of 1305 ppm was previously used as a positive control substance for 3 or 7 days treatment in female CD-1 mice and was shown to significantly increase Club cell proliferation (Strupp et al., 2012 (Strupp et al., , 2016 . Mortality, body weight, body weight gain, food consumption, gross pathology, and lung histopathology (light and electoron microscopy) were determined.
Histopathology
Lungs were fixed in buffered formalin, dehydrated, embedded in paraffin, sectioned, stained with hematoxylin and eosin, and examined by light microscopy. Lungs from some mice were inflated with 2.5% glutaraldehyde solution for electron microscopic evaluation, postfixed in 2% osmium tetroxide, dehydrated and embedded in epoxy resin. Ultrathin sections were prepared and stained with uranyl acetate and lead citrate, and examined by JEM-1400 transmission electron microscopy (JEOL, Tokyo, Japan).
Club Cell Proliferation Analysis by BrdU Labeling Indices
In experiment 1a, 500 mg 5-bromo-2 0 -deoxyuridine (BrdU, Sigma Aldrich) was dissolved in 50 ml saline. 24 and 2 hr before euthanization, all mice were given an intraperitoneal injection of BrdU at a dose of 100 mg/kg body weight (10 ml/kg body weight).
In the experiment using minipumps, 50 mg BrdU (experiments 1b and 2) or 40 mg BrdU (experiments 4a, 4b, and 6) was dissolved in 1 ml 10% DMSO. Alzet minipumps (Model 2001, Alzet corporation, Palo Alto, California, USA) were filled with 200-220 ml of this solution (40 or 50 mg BrdU/ml), and were implanted into the subcutaneous tissue of mice on the day prior to 7 days before the scheduled sacrifice. According to the manufacturer, the pump supplied 1 ml/h of BrdU for 7 days. This corresponds to a total release of: 50 or 40 mg/h Â 24 h/d Â 7 days ¼ 8.4 or 6.7 mg BrdU/mouse. In experiment 5, Alzet minipumps (Model 2ML2) had a total release of 33.6 mg BrdU/rat based on 40 mg BrdU/ml, 5 ml/h and 7 days treatment. To minimize the delay between implantation and the onset of release, the filled pumps were incubated in saline at 37 C-42 C for about 4 h immediately before implantation. The pumps were implanted subcutaneously in the back region under ether anesthesia and remained there until necropsy. After necropsy in each experiment, lungs and a segment of duodenum from each mouse were removed. Thin sections of the right lung anterior lobe, prepared from the same paraffin embedded blocks used for histopathology, were stained immunohistochemically using BrdU monoclonal antibody (DAKO; cat. no. M0744, diluted 250 times) to determine BrdU labeling indices. BrdU labeling indices for the lungs were calculated by dividing the number of labeled Club cell nuclei by the total number of Club cell nuclei of the terminal bronchiole times 100 (%). The total number of evaluated cells was >1000 per lung. Sections of duodenum were also prepared and stained immunohistochemically on the same glass slide using the BrdU monoclonal antibody as a positive control to confirm appropriate administration of BrdU.
Cell Proliferation Analysis of Lung by Ki-67 mRNA Expression After necropsy in Experimet 1a, a piece of the right lung anterior lobe was removed and then stored in RNA stabilization solution (Ambion, Austin, Texas) at -20 C until analyzed for gene expression. Total RNA was extracted from fresh lung from 4 mice per group using Trizol reagent (Invitrogen, California) and RNeasy Mini kit (Qiagen, Hilden, Germany) in accordance with manufacturer's instructions. Complementary DNA (cDNA) was prepared from total RNA by reverse transcription using the SuperScript III First-Strand Synthesis System for quantitative real-time (RT)-PCR (Invitrogen) according to the manufacturer's instructions. RT-PCR assays for mouse Ki-67 mRNA in lung from 3-and 7-day treatment animals were performed following the instruction manual of the PCR system (GeneAmp 5700 Sequence Detection System, Applied Biosystems). Level of mouse Ki-67 mRNA was determined as an indicator of cell proliferation. In addition, level of mouse Gapdh mRNA was determined as an internal control. The forward and reverse primer and probe sets were: GTGACAGTGGACAATCTTGCAAA, CGTGA GGTTACTGAAGTGTCTGTTG, CTGCCCAGCTCGTCTCCACCA CTAGA for Ki-67 mRNA; TGTGTCCGTCGTGGATCTGA, CCTGCTTCACCACCTTCTTGA, CCGCCTGGAGAAACCTGCCAAGT ATG for Gapdh mRNA; product size was 77 bp for both mRNA. The reaction mixture (25 ml) contained each primer (forward and reverse, 22.5 pmol each), 6.25 pmol probe, 12.5 ml TaqMan Universal Master Mix and 2 ml of a 1 in 4 dilution of the cDNA solution. After incubation at 50 C for 5 min and 95 C for 10 min, the PCR reaction was performed for 40 cycles: denaturation at 95 C for 15 s, anneal and extension at 60 C for 1 min. Ki-67 mRNA levels were normalized to those of gapdh mRNA. Each primer set did not form primer dimers or by-products and showed a single sharp peak under these conditions.
Gene Expression Profiling in Lung
Mouse Genome 430 2.0 Arrays, containing approximately 45 000 probe sets, were purchased from Affymetrix (Santa Clara, California). Total RNA samples were extracted from lung using an RNeasy Mini Kit (Qiagen) according to the manufacturer's instructions, before quantification and assessment of ribosomal RNA integrity using a 2100 Bioanalyzer (Agilent Technologies, Palo Alto, California, USA). Concentrations of the total RNA samples were measured by a Nano Drop 2000 spectrophotometer (Thermo Fisher Scientific, Wilmington, Delaware). For microarray probing, reverse transcription, second-strand synthesis, and probe generation were all accomplished with 3 0 IVT Express Kit (Affymetrix) following the manufacturer's protocol. Briefly, from 100 ng of total RNA, the double-strand cDNA was synthesized. From the double-strand cDNA, biotin-labeled cRNA was prepared and 15 lg of labeled cRNA was fragmented. The Mouse Genome 430 2.0 Arrays were hybridized as described in the Gene Chip Expression Analysis Technical Manual (Affymetrix). The arrays were stained and washed with Hybridization, Wash, and Stain Kit (Affymetrix), while the fluorescence was intensified by the antibody-amplification method. The arrays were scanned with a Genechip Scanner 3000 (Affymetrix) and the image files were obtained. Microarray data analysis was performed using the Affymetrix data suite system, Microarray Analysis Suite 5.0. Tab-delimited files containing data regarding the relative level of expression of a transcript (Signal) and whether a transcript is reliably detected or not (Detection Call; Present(P), Marginal(M), Absent(A)) from the image files have been obtained. The derived signal values were globally normalized and targeted to all probe sets equal to 100 before comparative analysis to examine gene expression differences between treatment and control samples. From the resulting tab-delimited files, signal averages of each group, the ratio of treatment to control and the P-value in statistical significance testing (Welch's t test, 2-sided) were obtained. All those showing !1.5 for the ratio and < 0.05 for the P-value, and "P (present)" for Detection Call in an experimental (treatment) array were regarded as up-regulated probe sets. Those showing 0.7 for the ratio and < 0.05 for the P-value, and "P (present)" for Detection Call in the baseline (control) array were regarded as down-regulated.
GO analysis was carried out with MataCore (GeneGo Inc., St Joseph, Michigan). The probability of a random intersection between a set of the IDs the size of target list with GO entities is estimated in P-value of hypergeometric intersection. The lower P-value means higher relevance of the entity to the dataset, which shows as a higher rating for the entity. The original GO cellular processes are represented at GeneGo. Since most of GO processes have no gene/protein content, the "empty terms" are excluded from P-value calculations.
Effect of permethrin on Cyp2f2 and Cyp2e1mRNA levels in lung of female mice (n ¼ 10) were determined in experiment 1b by the RT-PCR as described on Ki-67 mRNA. The forward and reverse primer and probe sets were: GCTGACGTCATCCCCATGA, ATCAGGAAGCCCCGGAAAG, and CTGCCTCACCGTGTCACTC GGGA (product size was 68 bp) for Cyp2f2 mRNA; ATCAACCTC GTCCCTTCCAA, GGGATGACATATCCTCGGAACA, and TGCCCC ACGAAGCAACCCGA (product size was 71 bp) for Cyp2e1 mRNA.
Statistical Analyses
Statistical analyses were performed with the statistical analysis system software (SAS, version 9.1). For experiments using multiple dose levels of test chemical, the data were initially tested for homogeneity using Bartlett's test. For the data found to be homogeneous (P > .05), Dunnett's multiple analysis was performed. If the data were not homogeneous (P .05), Steel's multiple analysis was performed. For experiments using a single dose level of test chemical, the data were initially tested for homogeneity using the F test for homogeneity of variance. If the variance was homogeneous, the data were analyzed by the Student's t test, and if heterogeneous, by the Aspin-Welch-test. Mann-Whitney's U test was used for analysis of the gradable histopathological findings, comparing test substance and control groups. The Fisher's exact probability test was similarly employed for analysis of clinical signs and gross pathological findings. Each evaluation except for BrdU labeling indices was by 2-tailed tests with 0.05 and 0.01 as the levels of significance. For the BrdU labeling indices, the significance of differences was estimated by 1-tailed at probability levels of 1% and 5%.
RESULTS
Experiment 1, Time-Course
Data of experiment 1a are presented in Table 2 . Treatment with permethrin revealed no deaths and did not affect body weight, body weight gain, or food consumption significantly, demonstrating that treatment with permethrin at 5000 and 10 000 ppm did not show excess toxicity for this exposure paradigm. Decreases of body weight, body weight gain, and/or food consumption were observed in the isoniazid group. Treatment with isoniazid showed significant increase of replicative DNA synthesis rate (determined as BrdU labeling indices using intraperitoneal injection method) of Club cells after the 3-day treatment period, and shortly thereafter no increase was observed, demonstrating that isoniazid has a transient enhancement of Club cell proliferation rate with a sharp peak effect within 1 week of treatment. No alterations in lung weight were observed with isoniazid. Permethrin 5000 ppm group also showed statistically significant increases of BrdU labeling indices for Club cells after 14-and 28-day treatment. The values of BrdU labeling indices were greater after 14-day treatment than 28-day treatment, whereas fold-change compared with the control group was greater after 28-day treatment than 14-day treatment; the foldchanges after 14-and 28-day treatments were 2.7-and 3.6-fold, respectively. After 7-day treatment, a few animals in the permethrin group showed higher labeling indices than those of controls, which contributed to a higher mean value but without statistical significance because of the marked variability between all of the mice. Slightly higher values (statistically not significant) of expression of Ki-67 mRNA were also observed after 3-day but not 7-day treatment with isoniazid 2500 ppm, and observed after 7-day but not 3-day treatment with permethrin 5000 ppm. These findings were consistent with alterations of BrdU labeling indices.
Furthermore, in experiment 1b using continuous treatment of BrdU by osmotic minipump, similar but clearer findings than in experiment 1a were observed at 5000 ppm (and at 10 000 ppm) indicating reproducibility of the finding (Table 3 ). These data demonstrated that permethrin continuously enhanced Club cell proliferation; however, the enhancement was less than the peak effect by isoniazid.
Histopathological examination by light microscopy did not reveal any abnormalities (data not shown), but examination by electron microscopy revealed alterations of morphology of Club cells in both permethrin and isoniazid groups (Tables 2 and 3 ): dilatation and/or proliferation of smooth-surfaced endoplasmic reticulum (SER) (Figure 1 ), decreased secretory granules, increased incidence of Club cells with blebs and increased incidence of Club cells containing elongate-type mitochondria ( Figure 2 ). There was no evidence indicating abnormality in other lung cell types.
The analyses of global gene expression profile demonstrated that permethrin treatment altered gene expression with a dose dependence with respect to both gene number (Table 4) Table 4 , the number of probe sets changed by permethrin 5000 ppm was more in 14-day than in 7-day treatment (approximately 2-fold; 7-vs 14-day: 31 vs 60). However, the increase of the number of probe sets at 10 000 ppm between 7-and 14-day treatment was slight (7-vs 14-day: 78 vs 87).
Overlap of gene sets altered by 7-day treatment with permethrin 5000 ppm was compared with those after 14-day treatment: 63% (15 of 24 probe sets) were commonly upregulated after both 7-and 14-day treatment. The common upregulated genes at both 7-and 14-day treatment are shown in Table 4 . Most of the common genes are known to be related to metabolic processes of various substances, whereas thioredoxin reductase 1 (Txnrd1) is known as a gene directly related to cell proliferation (Fernandes et al., 2009) . None of the downregulated genes overlapped for the 2 treatment times.
The same analysis was conducted on the permethrin 10000 ppm group. Common up-regulated genes at both 7-and 14-day treatments in the 10 000 ppm group include all of the common genes in the 5000 ppm group. None of the downregulated genes overlapped for the 2 treatment periods.
To translate the information obtained from individual genes into a broader characterization, GO analysis was carried out with MataCore. As shown in Supplementary Figure 4 , of the top 10 GO cellular processes in the permethrin group, most processes were metabolism-related processes such as "metabolic process," "cellular response to xenobiotic," and "response to xenobiotic stimulus." However, no significant changes were observed in the mRNA level of either Cyp2e1 or Cyp2f2 after 7-and 14-day treatment with permethrin at 5000 and 10 000 ppm (Table 3) .
No GO process overlapped with the isoniazid group except for "response to chemical stimulus" after 7-day treatment (Supplementary Figure 4) . However, this is understandable as isoniazid was used in our study as a positive control for Club cell proliferation at an early phase of treatment (Strupp et al., 2012 (Strupp et al., , 2016 , not necessarily by the same MOA. After 7-day The number of animals with findings/the number of animals examined. SER: Smooth-surfaced Endoplasmic Reticulum. Significantly different from the control group (*P < .05; **P < .01).
treatment, the isoniazid group revealed alterations of many GO cellular processes involving response to various biological substances, chemical stimuli, stress, etc. However, these GO cellular processes were not observed after 14-day treatment with isoniazid, indicating that most responses were transient. These findings were consistent with the transient increase of Club cell proliferation.
Experiment 2, Dose-Response, Reversibility, and Sex Difference Data of this experiment are shown in Table 5 . Although 1 animal treated with permethrin 10 000 ppm was found dead at day 3 (cause of death is unknown but probably due to lower food consumption due to palatability issues), no deaths were observed in the other animals and treatment with permethrin did not affect final body weight, total body weight gain, or average food consumption, demonstrating that treatment with permethrin did not show excess toxicity in this study conditions (Table 5) . Increases of the BrdU labeling indices of Club cells were observed in females at 2500 ppm and above groups; small (Â 2.1) but statistically significant increases were observed at 2500 and 10 000 ppm; and 5000 ppm (Â 1.8) was close to significant (P ¼ .06). No significant alterations of BrdU labeling were observed in male mice, correlating with lack of lung tumor induction in the long-term bioassay. Histopathological examination by electron microscopy revealed morphological alterations such as increased abnormality of mitochondria (elongated and irregular) at 2500, 5000, and 10 000 ppm, proliferation of SER at 10 000 ppm and decreased secretory granules in the females at 500 ppm and higher (Table 5) . Although decreased secretory granules were also observed in males at 5000 ppm, there were no increases of SER proliferation or abnormal mitochondria in Club cells of males.
All alterations of BrdU labeling indices and morphological alterations in the female mice returned to control levels after the recovery period (Table 5) .
Experiment 3, Acute Cytotoxicity
There was no death in any group. Body weights of mice in the treated groups were comparable to that in the control group. However, in all groups, including control, body weights at 1 day after treatment were marginally decreased compared with those before treatment. Permethrin at 10 000 ppm showed significantly decreased body weight gain. Significant suppression of food consumption was observed in the groups administered permethrin at 5000 and 10 000 ppm and coumarin at 200 mg/kg. Under such conditions, chemical intake at 5000 and 10 000 ppm permethrin was 423 and 456 mg/kg/d, respectively. These intake levels were higher than the dose levels associated with increased Clara cell proliferations after 7-day treatment (experiment 2, 2500 ppm; 365 mg/kg/d) and dose levels by oral gavage in this experiment (150 mg/kg).
Morphological alterations of Club cells were observed in mice treated with coumarin and isoniazid (Table 6 ). In the coumarin group, necrosis/degeneration was observed in Club cells but not in ciliated cells. Therefore, this effect was Club cell-specific toxicity.
FIG. 1. Electron photomicrographs of Club cells in control (A)
, 2500 ppm isoniazid (B) or 5000 ppm permethrin (C)-treated female CD-1 mice after 3-days of treatment. Dilatation of SER was observed in (B) and (C). SER, smooth endoplasmic reticulum; mr, mitochondria (round-type). Scale bars represent 500 nm.
FIG. 2.
Electron photomicrographs of Club cells in control female CD-1 mice after 3-days of treatment (A), in female mice given 2500 ppm isoniazid (B), or 5000 ppm permethrin (C) after 7-days of treatment. Elongated mitchondria were observed in (B) and (C). mr, mitochondria (round-type); me, elongated mitochondria. Scale bars represent 2.0 lm. Aldh3a1, AU018778, Blvrb, Cbr3, Ces1, Entpd5, Gclc, Gpx2, Gsta1/2, Gsta2, Gstm1, Pgd, Srxn1, Txnrd1, Ugt1a1/10/2/5/6a/6b/7c/9
Abcb6, Abcc3, Acox2, Aldh3a1, AU018778, Blvrb, Cbr1, Cbr3, Ces1, Cldn8, Cyp2a4/5, Entpd5, Ephx1, Esd, Gclc, Gclm, Gpx2, Gsr, Gsta1/2, Gsta2, Gsta3, Gstm1, Gss, LOC630729, Pgd, Srxn1, Txnrd1, Ugt1a1/10/2/5/6a/6b/7c/9 Down-regulated None None
Probe sets were considered as differentially expressed when the average signal value of the "treatment" had to be more than 100, 5 "P" calls had to be in the 5 animals in the array, the fold change had to be 1.5 or higher (ratio of average signal value), and the result of the t test had to be an "Up"-change call (P < .05) based on signal values of 5 animals) for up-regulated genes; the average signal value of the "control" had to be more than 100, 5 "P" calls had to be in the 5 animals in the array, the fold change had to be 0.7 or less (ratio of average signal value), and the result of the t test had to be an "Down"-change call (P < .05) based on signal values of 5 animals) for down-regulated genes. For 7-day treatment, numbers in parentheses are genes that are also altered at 14-day treatment; ie, commonly altered genes at both 7-and 14-day treatment. Of commonly altered genes at 7-and 14-day treatment, commonly altered genes at both 5000 and 10 000 ppm are highlighted with bold and underline. [100]
[86]
[130]
[210]
[175]
Electoron microscopy The number of animals with findings/the number of animals examined. Significantly different from the control group (*P < .05; **P < .01).
In the high dose group, thinning of ciliated cells also appeared to cover the space of Club cell detachment. In the isoniazid group, slight to moderate vacuolation was observed lightmicroscopically, which was consistent with moderate to severe dilatation of SER observed by electron microscopy (Table 7) . However, no necrotic or inflammatory findings were observed with isoniazid treatment. Permethrin treatment, irrespective of feeding or oral gavage (5000 and 10 000 ppm in diet, and 150 mg/ kg by gavage), did not reveal any remarkable alterations compared with the control group. Necrotic or inflammatory changes in Club cells and ciliated cells were also not observed in mice treated with permethrin. Thus, permethrin did not cause any cytotoxicity (increased cell death) in the lung, demonstrating that the pattern of proliferative effects is a mitogenic effect by permethrin rather than cytotoxicity with consequent regenerative proliferation.
Experiment 4, Strain Difference in Mice
To confirm the hypothesis that a high dose of permethrin causes lung neoplasms in the susceptible strain of an animal species such as mice, we evaluated whether increased Club cell proliferation by permethrin was observed in a number of mouse strains (Table 8) . Control levels of BrdU labeling indices were slightly higher in BALB/cAnN (3.3%) than in C57BL/6N (2.0%). Permethrin treatment increased the labeling indices in both strains; the absolute value of the labeling index was also higher in BALB/cAnN (14.3%) than C57BL/6N (10.4%) strain mice. Although these findings were in accord with susceptibility for spontaneous lung tumor appearance, fold change compared with control by permethrin treatment differed little between BALB/cAnN (Â4.3) and C57BL/6N (Â5.2) for strains. We also examined the effect of permethrin on Club cell proliferation in another mouse model. The Avy mouse is With sloughing/cell debris in the lumen. Significantly different from the control group (*P < .05; **P < .01). 
-, Within normal limits; 6, slight; þ, mild; þþ, moderate; þþþ, severe. SER, smooth-surfaced endoplasmic reticulum.
genetically identical to C57BL/6J mouse but is susceptible to chemically induced tumor production (Yen et al., 1994) . Three of ten C57BL/6J mice treated with permethrin 10 000 ppm were found dead or moribund at sacrifice, whereas other animals revealed no deaths and no overt evidence of severe toxicity except for suppression of body weight and food consumption (Table 8) . Control levels in BrdU labeling in Club cells were the same in Avy and C57BL/6J mice (4.9% and 5.0%, respectively), whereas the absolute value and fold change by permethrin treatment were higher in Avy mice (14.5%, Â3.0 of control, respectively) than in C57BL/6J mice (9.5%, Â1.9 of control, respectively). These data demonstrate that permethrin also increased Club cell proliferation in a susceptible mouse strain for chemically induced lung tumor production.
Experiment 5, Species Difference Between Mouse and Rat
Female HarlanRccHanTM:WIST rats were fed diets containing 0 (control) or 2500 ppm permethrin for 7 days ( Table 9 ). The treatment with permethrin revealed no deaths and did not affect body weight or food consumption significantly, demonstrating that treatment with permethrin at 2500 ppm did not show excess toxicity. As mentioned in the "Materials and Methods" Values represent mean 6 SD, n ¼ 10. Significantly different from the control group (* P < .05; ** P < .01). Section, 2500 ppm is an appropriate dose level to be examined in the present experiment. Treatment with permethrin showed no increase of BrdU labeling indices in bronchiolo-alveolar epithelial cells after 7-day treatment period in female Wistar rats. Histopathological examination by electron microscopy revealed no overt changes observed in the lung from the permethrin group.
Experiment 6, Comparison With Cypermethrin
In this experiment, treatment with isoniazid at doses of 600 and 1000 ppm showed a significant increase of BrdU labeling indices of Club cells after 7-day treatment period and shortly thereafter no increase was observed (Table 10) , consistent with the previous experiment using a higher dose level (2500 ppm) of isoniazid (Table 3) . Treatment with cypermethrin also showed a small increase in BrdU labeling indices of Club cells at 1600 ppm (Â1.4-1.5) and 2100 ppm (Â1.3-1.8) after 7-and 14-day treatment. Thus, these data demonstrated that cypermethrin has a weak mitogenic effect on Club cells in mouse lung similar to permethrin. The potency of enhancement of Club cell proliferation at the highest dose level in the mouse carcinogenicity study (ie, maximum tolerated dose level) was similar between cypermethrin (Â1.5 at 1600 ppm) and permethrin (Â2.1 at 2500 ppm). However, its potency was much less than that of isoniazid, corresponding, however, to the differences in potencies in the induction of mouse lung tumors. Histopathological examination by light microscopy did not reveal any abnormalities (date not shown), but examination by electron microscopy revealed alterations of morphology in Club cells in the cypermethrin groups: dilatation of SER, proliferation of SER and increased incidence of Club cells containing elongate-type mitochondria (Table 10 ). The increase of elongated mitochondria was also observed at 600 and 1000 ppm of isoniazid. The alterations of SER were not observed in this experiment but were previously observed at 2500 ppm of isoniazid (Tables 2 and 3 ). Taken together, these findings provided evidence for a similarity of effects of cypermethrin and permethrin on mouse lung at the early phase of treatment, as evidenced by similar enhanced cell proliferation and morphological alterations by electron microscopy of Club cells.
DISCUSSION
MOA Data
Since increased cell proliferation often represents an essential pre-neoplastic step in carcinogenesis by nongenotoxic substances (Cohen and Arnold, 2011; Wood et al., 2015) , the present study focused mainly on evaluation of the effect of permethrin on Club cell proliferation.
Experiment 1a was conducted to determine the time-course effect of permethrin on Club cell proliferation during 28 days of treatment. In this experiment, treatment with isoniazid, a positive control for Club cell mitogen, showed a transient enhancement of Club cell proliferation rate with a sharp peak effect within 1 week of treatment (Table 2) , consistent with previous studies with other chemicals (Strupp et al., 2012 (Strupp et al., , 2016 . This suggests that appropriate experimental conditions were employed in these studies. Statistically significant increases in BrdU labeling indices in Club cells were observed after 14-and 28-day treatments with 5000 ppm permethrin (Table 2 ). However, after The number of animals with findings/the number of animals examined.
7-days treatment, only a few animals in the permethrin group showed higher labeling indices than those of controls. Thus, the mean value was higher than control but was without statistical significance due to the marked variation between animals. Taking account of the slightly higher (statistically not significant) expression of Ki-67 mRNA expression observed after the 7-day treatment with 5000 ppm permethrin (Table 2) , it was suggested that 5000 ppm permethrin ppm may also increase Club cell proliferation after 7-day treatment. To confirm this possibility, an additional experiment (experiment 1b) was conducted using BrdU administration by minipump rather than i.p. injections, and showed significantly increased Club cell proliferation after 7-and 14-day treatment with 5000 and 10 000 ppm permethrin (Table 3) . These results convincingly show that permethrin produces mitogenic effects in mouse Club cells after short periods of treatment. Apart from cell proliferation, permethrin also induced morphological alterations in Club cells, detected only by electron microscope examination (EM) but not by light microscopic examination. The findings by EM in the lung of permethrintreated mice were minor but were limited to Club cells with no evidence of abnormalities in other lung cell types. These findings were not observed at day 1 (Table 7) but were observed at and after day 3 (Tables 2, 3 , and 5), suggesting that morphological alterations were induced prior to the increased Club cell proliferation. The EM findings included proliferation of SER, increased elongated/irregular mitochondria, and decreased secretory granules. The findings observed in the present study are known to be associated with acceleration of xenobiotic metabolism and oxidative phosphorylation (Kitamura et al., 1987; Van Winkle et al., 1999) . They were also consistent with the findings in gene expression analysis; GO analysis with MataCore revealed that most of the top 10 GO cellular processes in the permethrin group were metabolism related processes. The dose levels at which slight morphological effects on Club cells occurred were concordant with doses producing increased tumor incidences. Therefore, it is reasonable to conclude that these effects are chemically induced precursor events.
For hepatocyte tumorigenicity, mitogenicity via nuclear receptors such as constitutive androstane receptor (CAR) and peroxisome proliferator-activated receptor a (PPARa) is a critical first key event for the tumor MOA, and CYP2B for CAR and CYP4A for PPARa are associative events (biomarker of the first key event) (Corton et al., 2014; Elcombe et al., 2014) . Similarly, the slight morphological alterations observed in Club cells might be a biomarker for an initial event. Since the precise molecular mechanism for the MOA for permethrin lung tumor induction is unknown, additional research to determine molecular events for the relationship between the morphological effects and the increased proliferation of Club cells will be useful. However, this level of molecular mechanistic understanding is not necessary for conclusions regarding the MOA. Enhancement of Club cell proliferation was observed at both 7-and 14-day treatments in the 5000 and 10 000 ppm groups, and a number of common genes altered by both 7-and 14-day treatments at both 5000 and 10 000 ppm permethrin were detected (genes with bold in Table  4 ). They may contribute to the molecular mechanism for permethrin-induced mitogenic activity in lung Club cells. Further research is needed to confirm this hypothesis.
In this study, acute exposure of coumarin induced cytotoxicity in mouse Club cells but permethrin did not (Tables 6 and 7) . It is unlikely that cytotoxicity occurred and recovered before the observation times because the time for recovery before observation was too short. Mice eat during the night and early morning, and the necropsy in this study was conducted at 9:30-11:30 AM. In addition, no cytotoxic findings were detected following acute oral gavage (dosed approximately 24 hours before necropsy) or by 3-days dietary treatment. Consequently, it is reasonable to conclude that permethrin does not produce cytotoxicity in mouse lung Club cells.
Assessment of the Proposed MOA According to the IPCS/ Human Framework
Postulated MOA for the induction of lung tumors in female mice In many cases, it is clear that toxicity (even involved with possible carcinogenesis) arises secondary to some early occurring toxic event (Cohen and Arnold, 2011) . By examining the mechanisms involved in these early events, considerable progress can be made more quickly in delineating the actual mechanisms (Cohen and Arnold, 2016) . The sequence of specific key events in the tumorigenic MOA for effects of permethrin on lung is postulated to include: morphological effects on Club cells following systemic chemical exposure, increased Club cell proliferation, and eventually hyperplasia and bronchiolo-alveolar adenoma. The postulated mouse MOA was evaluated according to the IPCS framework (Boobis et al., 2006 (Boobis et al., , 2008 Cohen et al., 2004; Meek et al., 2003; Sonich-Mullin et al., 2001) . The summary of the MOA data in a dose-temporality format is presented in Table 11 .
Concordance of Dose-Response Relationship
Club cell proliferation, expected as a main key event for lung tumorigenicity in CD-1 mice, was evaluated with respect to dose response. Whereas no meaningful alterations were observed at 20 and 500 ppm, some animals with higher levels of BrdU labeling indices were noted at 2500, 5000, and 10 000 ppm in female CD-1 mice. Electron microscopy revealed alterations of morphology of Club cells at 2500, 5000, and 10 000 ppm but not at 20 and 500 ppm in female CD-1 mice. The increased cell proliferation (ie, mitogenic effect) and the alterations of morphology of Club cells had an apparent threshold dose between 500 and 2500 ppm in females. In male CD-1 mice, however, no obvious alterations were observed even at 5000 ppm. The incidence of lung tumors (adenoma) was significantly increased in female CD-1 mice administered 2500 and 5000 ppm, but no increase in lung tumors occurred in male CD-1 mice administered up to 2000 ppm. Therefore, there are strong parallels in the dose response for altered morphology of Club cells, cell proliferation and the tumor response.
Temporal Association
If a key event (or events) is an essential element for carcinogenesis, it must precede the appearance of the tumors (Cohen and Arnold, 2016) . This is clearly the case for permethrin-induced mouse lung tumors. Multiple exposure time data at 1, 3, 7, 14, and 28 days, at 39, 52, 65, and 78 weeks, and 2 years are available in which female CD-1 mice were fed diets containing 5000 ppm permethrin in the present and previous studies (US. EPA, 2002) . One day treatment with permethrin did not induce any morphological alteration of Club cells as evaluated by both light and electron microscopic examination. However, morphological changes in Club cells were observed by ultrastructural examination after treatment for 3, 7, 14, and 28 days. The treatment of female mice with 5000 ppm permethrin for 3 days did not produce any increase in Club cell replicative DNA synthesis (as assessed by intraperitoneal administration of BrdU), whereas treatment for 7, 14, and 28 days resulted in increases in replicative DNA synthesis (assessed by both intraperitoneal administration of BrdU and by use of osmotic minipumps). The chronic administration of 5000 ppm permethrin to female mice resulted in sustained Club cell hyperplasia which was observed after 39 (the earliest time point examined), 52, 65, and 78 weeks of treatment (unpublished data referred to US.EPA, 2002). Overall, there is a logical temporal response for all key events for permethrin-induced mouse lung tumor formation, in which all effects on the key events precede tumor formation, and appear in appropriate sequence for the stated MOA.
Strength, Consistency, and Specificity of Association of Tumor Response With Key Events
The strength, consistency and specificity of the association between the identified key events and subsequent tumor formation are demonstrated by the data obtained in a number of studies. Apart from studies in CD-1 mice, permethrin was also shown to increase Club cell replicative DNA synthesis in other mouse strains. Although permethrin increased replicative DNA synthesis in female mouse Club cells, no such effect was observed in male mice, which correlates with the lack of tumor formation in male mice. Furthermore, it is noteworthy that the degree of increased cell proliferation was relatively mild, consistent with the slight increase in tumor incidences, particularly when compared not only to the concurrent controls but to the range of historical controls. This is also consistent with the increase being only in benign adenomas and not in carcinomas, which is different from a potent lung tumor inducer, isoniazid, that induced adenocarcinoma of the lung (Maru et al., 1980) . It is also important that no increase was observed in morphologic alterations or in cell proliferation in rats administered permethrin, correlating with a lack of tumorigenic response in rats.
The relationship of the observed effects on female mouse lung Club cells to permethrin treatment was demonstrated in a recovery study, where the effects of permethrin were shown to be reversible on cessation of treatment. Female CD-1 mice were given 10 000 ppm permethrin for 7 days followed by 5 weeks of no treatment. Although permethrin produced ultrastructural changes in lung Club cells and stimulated replicative DNA synthesis after 7 days treatment, no such effects were observed after 5 weeks of recovery.
Cypermethrin is a close structural analog of permethrin that induced lung tumors in female mice (US. EPA, 2003) . Female CD-1 mice were given diets containing the highest bioassay dose level of 1600 ppm cypermethrin and also a higher dose level of 2100 ppm cypermethrin for 7 and 14 days. As a positive control, female CD-1 mice were given diets containing 600 and 1000 ppm isoniazid for 7 and 14 days. Morphological examination of mouse lung sections by light microscopy did not reveal any changes following treatment with cypermethrin. However, ultrastructural examination by electron microscopy revealed proliferation of the SER of Club cells following treatment with cypermethrin for 7 and 14 days. In addition, treatment with cypermethrin and isoniazid for 14 days was shown to increase the numbers of elongated mitochondria in mouse lung Club cells. The treatment of mice with 1600 and 2100 ppm cypermethrin for 7 days resulted in increases in Club cell replicative DNA synthesis to 149 and 179% of control, respectively, with treatment with 600 and 1000 ppm isoniazid producing large increases in Club cell replicative DNA synthesis. Overall, the effects of cypermethrin on female CD-1 mouse lung Club cells were similar in this study to those of isoniazid and to those produced in other studies by both permethrin and isoniazid. This study with a close structural analog of permethrin also demonstrates the strength, consistency, and specificity of the association between enhanced Club cell replicative DNA synthesis and mouse lung tumor formation. Date of the 2-year bioassay are referred from the 2nd study (100-week feeding mouse study) in which female mice were exposed to permethrin at a dose of 5000 ppm in the diet for various lengths of time (39, 52, 65 and 78 weeks) followed by removal of treatment of permethrin (T: Treatment periods, R: Recovery periods) (Unpublished data referred to US.EPA, 2002).
Biological Plausibility and Coherence
The lung is the second commonest target tissue affected in mouse cancer bioassays, with some strains having high background incidences and being highly susceptible to tumorigenic effects (Gold et al., 2001; Huff et al., 1991) . In the tumorigenicity studies of permethrin, a marked difference in sensitivity between mice and rats was noted (US.EPA, 2002). In mice, lung tumors were seen following exposures of 2500 ppm of permethrin, whereas lung tumors were not seen in rats at the same dose level (2500 ppm). The differences in sensitivity of the mouse compared with the rat with respect to lung tumor formations are also observed with many chemicals, such as isoniazid, flonicamid, fluensulfone, coumarin, 4-methylimidazole, naphthalene, styrene, trichloroethylene (Cruzan et al., 2009 (Cruzan et al., , 2012 (Cruzan et al., , 2015 Green, 2000; IARC, 1987; Strupp et al., 2012 Strupp et al., , 2016 US.EPA, 2005) . Therefore, it is reasonable to conclude that the high dose of permethrin that induced lung neoplasms is related to a susceptible animal species such as mice, and this effect is not limited to permethrin. This is also supported by evidence that permethrin increased Club cell proliferation in mice irrespective of strain (CD-1, BALB/cAnN, C57BL/6N, Avy [C57BL/6J background]) (Tables 2, 3 , 5, and 8) but not in rats (Table 9 ), demonstrating that mice are susceptible for permethrin-induced lung tumorigenicity. The proposed MOA for mouse-specific lung tumor development is in agreement with broadly accepted knowledge that cell proliferation is the main underlying process which leads to development of tumors by nongenotoxic compounds (Strupp et al., 2012 (Strupp et al., , 2016 Wood et al., 2015) . Concerning sex specificity, permethrin increased mouse lung tumors only in female mice consistent with the increased Club cell proliferation only in female mice. In the literature, this female specific effect is limited to permethrin and fluensulfone (Strupp et al., 2012) , but not to several other mouse lung tumorigens such as isoniazid, flonicamid, coumarin, 4-methylimidazole, naphthalene, and styrene, where lung tumors were observed in both male and female mice (Cruzan et al., 2009 (Cruzan et al., , 2012 (Cruzan et al., , 2015 IARC, 1987; US.EPA, 2005) . Therefore, sex specificity is compound specific. Although the factor(s) responsible for sex specificity are unknown, these may be due to differences in metabolism.
The plausibility of the proposed mitogenic MOA of permethrin is also supported by that of other chemicals with a similar mitogenic MOA (eg, isoniazid, flonicamid, and fluensulfone) (IARC, 1987; Strupp et al., 2016; US.EPA, 2005) , but is clearly different from chemicals with a cytotoxic MOA (Born et al., 1998 , Cruzan et al., 2012 Green et al., 2001b; Van Winkle et al., 1999; West et al., 2000) (discussed below).
Other Modes of Action
Other known MOAs for rodent lung carcinogenesis have been assessed from the data available from the various studies performed with permethrin. As described previously (US.EPA, 2002), a series of genotoxicity studies indicate that permethrin is not mutagenic in the bacterial reverse mutation and mouse lymphoma assays; permethrin is also negative for clastogenicity in a mouse micronucleus assay and does not cause unscheduled DNA synthesis in primary rat hepatocytes; and there is no evidence of increased dominant lethal mutation in the germinal cells of mice, suggesting that permethrin has no genotoxic potential. Thus, permethrin-induced mouse lung tumor formation is attributable to a nongenotoxic MOA and is associated with increased cell proliferation (Cohen and Arnold, 2011; Wood et al., 2015) .
Increased cell proliferation can be produced either by direct mitogenesis or by cytotoxicity, such as necrosis, with consequent regenerative proliferation (Cohen and Arnold, 2011) . Club cells are known to be a target for lung carcinogenesis in mice (Cruzan et al., 2009 (Cruzan et al., , 2012 (Cruzan et al., , 2015 Green, 2000; IARC, 1987; Strupp et al., 2012 Strupp et al., , 2016 US.EPA, 2005) . A number of chemicals have been shown to produce lung tumors in mice by a MOA that involves cytotoxicity to Club cells. Examples of such chemicals include coumarin, ethylbenzene, methylene chloride, naphthalene, styrene, and trichloroethylene (Born et al., 1998; Cruzan et al., 2009 Cruzan et al., , 2012 Cruzan et al., , 2015 Foster et al., 1992 Foster et al., , 1994 Green, 2000; Green et al., 1997 Green et al., , 2001b . The morphological effects of a number of nongenotoxic cytotoxic mouse lung Club cell carcinogens are known to reverse quickly due to tolerance (Born et al., 1999; Foster et al., 1992; West et al., 2000) . In this study, the acute effect of permethrin on female mouse lung Club cells was investigated by administering permethrin both by gavage or in the diet for 1 day, with a single oral dose of coumarin being employed as a positive control. Acute treatment with permethrin did not induce cytotoxic effects in mouse lung Club cells. In addition, there was no evidence of necrosis or inflammatory changes in mouse lung following permethrin treatment for up to 28 days. Therefore, this study provides clear evidence to exclude a cytotoxic MOA for permethrin-induced mouse lung tumor formation, thus leaving increased mitogenesis as the most plausible MOA for producing increased cell proliferation.
Immunosuppression can also be excluded, since general toxicity studies with permethrin were negative for parameters related to this endpoint such as inflammation or histopathologic alterations on lymphoid and hematopoietic tissues such as thymus, spleen, lymph nodes, Peyer's patches, and bone marrow or hematologic alterations regarding white blood cells (JMPR, 1999) .
Uncertainties, Inconsistencies, and Data Gaps
The tumors occur in the periphery of the lungs where terminal bronchioles and alveoli are in intimate contact. Depending on the tissue section examined, terminal bronchioles may or may not be visible. The tumors displace normal bronchiolar and alveolar tissues and based on histopathology, it is not possible to determine whether the tumors arise from alveolar tissue or terminal bronchiolar tissue. Although there is no direct evidence that the mouse lung tumors caused by permethrin are derived from Club cells, the results of the ultrastructural and cell proliferation studies demonstrate that Club cells and not other lung cell types are affected by permethrin treatment. In addition, Club cell hyperplasia, which is a preneoplastic lesion, was observed in a long-term study with permethrin (unpublished report referred to US.EPA, 2002). Furthermore, cypermethrin, a close structural analog to permethin, also increased Club cell proliferation and produced morphological alterations (this study) and lung tumors in female mice (US.EPA, 2003) . Overall, it is highly likely that the primary target for tumorigenesis of the lung by permethrin is the Club cell.
As mentioned earlier, a number of chemicals have been shown to produce mouse lung tumors by a cytotoxic MOA. For some compounds, such as coumarin, fluensulfone, naphthalene, and styrene, this is due to metabolic activation to toxic products catalysed by mouse CYP2f2 (Cruzan et al., 2009 (Cruzan et al., , 2012 Strupp et al., 2016) . The analysis of global gene expression profiles and GO data actually suggests enhancement of metabolic processes which secondarily result in permethrin-induced stimulation of Club cell proliferation and then lung tumor formation. However, treatment with permethrin for 7 or 14 days did not increase mouse lung Cyp2f2 mRNA levels. Although it is unknown whether permethrin can be metabolized by mouse lung Cyp2f2, this is not critical for the proposed MOA for mouse lung tumor formation, where permethrin produces a mitogenic rather than a cytotoxic effect on mouse lung Club cells. In addition to Cyp2f2 mRNA, Cyp2e1 mRNA expression was also not increased by permethrin treatment, suggesting that metabolic activation by either CYP2f2 or CYP2e1 is unlikely to contribute to permethrin-induced lung tumor production.
Of chemicals with mitogenic activity to Club cells, different patterns of increased cell proliferation have been observed. Isoniazid (1305 ppm) showed a transient increase in female mice but a sustained increase in male mice when examined at 3-and 7-day treatments (Strupp et al., 2016) , and isoniazid (600, 1000, or 2500 ppm) showed a transient increase in female mice when examined at 3-, 7-, 14-, or 28-day treatments (this study). Fluensulfone (1200 ppm) showed a transient increase in both sexes of mice when examined at 3-and 7-day treatments (Strupp et al., 2016) . Flonicamid (2250 ppm)-induced cell proliferation was identified as early as 3 days and present through 28 days of treatment (ECHA, 2012; US.EPA, 2005) . In this study, permethrin (5000 ppm) also increased Club cell proliferation as early as 7 days and throughout 28 days of treatment. Although the detailed mechanisms of the observed differences in proliferation patterns are unknown, these might include differences in proliferation potency or metabolism of the compounds.
Assessment of Postulated MOA
As described earlier, the key events in the MOA for permethrininduced mouse lung tumor formation have been identified and shown to exhibit a strong dose and temporal consistency with tumor formation (Table 11) . Unlike some other mouse lung Club cell nongenotoxic carcinogens (such as coumarin, dichloromethane, ethylbenzene, fluensulfone, naphthalene, styrene and trichloroethylene), permethrin is a mitogenic agent in mouse lung Club cells and hence does not increase cell proliferation by cytotoxicity and consequent regenerative proliferation. The proposed MOA for permethrin-induced mouse lung tumor formation is similar to the mitogenic MOAs previously described for the formation of mouse lung tumors by isoniazid, flonicamid, and fluensulfone. Cypermethrin, which is structurally related to permethrin, has also been shown to produce lung tumors in mice by a mitogenic effect on Club cells.
The postulated rodent MOA was tested against the modified Bradford Hill considerations based on the IPCS framework and was found to satisfy the conditions of dose and temporal concordance, biological plausibility, coherence, strength, consistency, and specificity that fit with an established MOA for lung tumors. Alternative MOAs for both permethrin-induced lung tumor formations were excluded. It is considered that there is a high level of confidence in the proposed MOA for permethrininduced mouse lung tumor formation.
Discussion and Conclusion Regarding Human Relevance of the MOA
The human relevance of the postulated MOA for permethrininduced mouse lung tumors was evaluated using the IPCS Human Relevance Framework, which was developed from the Risk Sciences Institute/International Life Sciences Institute "Human Relevance Framework" (Meek et al., 2003) and modified by the IPCS Cancer Working Group (Boobis et al., 2006) . This framework presents a 4-part approach to addressing a series of 3 questions leading to a transparent, documented, logical conclusion regarding the human relevance of the MOA underlying the animal tumors. Question 1. Is the weight of evidence sufficient to establish a MOA in animals? As described earlier, there is clear evidence that following systemic exposure permethrin produces ultrastructural morphological changes in Club cells followed by a mitogenic effect resulting in increased Club cell proliferation. Prolonged administration of permethrin results in Club cell hyperplasia and subsequently in the formation of bronchiolo-alveolar adenomas. Alternative MOAs of genotoxicity, cytotoxicity with consequent regenerative proliferation, and immunosuppression were excluded. Hence, the answer to question 1 is yes.
Question 2. Can human relevance of the MOA be reasonably excluded on the basis of fundamental, qualitative differences in key events between experimental animals and humans? The current understanding of increased Club cell proliferation as a risk factor for tumor formation was considered to assess the human relevance of the key events in the proposed MOA for permethrin-induced mouse lung tumor formation. This is supported by evidence that susceptible animals (ie, mice, irrespective of strain) for chemically induced lung carcinogenicity are also susceptible to enhancement of Club cell proliferation at an early stage of treatment with permethrin. As the fundamental mechanisms involved in the stimulation of cell proliferation in mouse lung Club cells have not been fully elucidated and humans have lung Club cells, human relevance of the proposed MOA cannot be excluded on a qualitative basis. However there are substantial quantitative dynamic differences between mice and humans, as discussed below.
Question 3. Can human relevance of the MOA be reasonably excluded on the basis of quantitative differences in either kinetic or dynamic factors between experimental animals and humans? As shown in a concordance table (Table 12) comparing female mice (susceptible) and male mice and rats (resistant) to humans, important quantitative differences between mice, rats, and humans exist and include:
1. Mice have a significantly higher proportion of Club cells within the terminal bronchioles compared with rats, with rats having greater proportions of Club cells than humans (Lumsden et al., 1984; McDowell et al., 1978; Plopper et al., 1980a; Smith et al., 1979) ; 2. The metabolic capacity such as xenobiotic (eg, CYP) metabolism of human nasal and lung tissue is significantly less than that of rodents (Carlson, 2008; Cruzan et al., 2009; Gervasi et al., 1991; Green et al., 1997 Green et al., , 2001a Lewis et al., 1994 Lewis et al., , 2009 Mattes and Mattes, 1992; Saghir et al., 2009; Vassallo et al., 2004) ; 3. Club cells differ morphologically among species, with human cells containing little SER compared with mice (Plopper et al., 1980a,b; Smith et al., 1979) ; correlating with differences in metabolic activity; 4. The pathogenesis of lung tumors also exhibit clear species differences, as adenomas that occur in humans (rare tumors) are not considered premalignant lesions (Hahn et al., 2007; Travis et al., 2004) .
5. The background rates for lung tumors are considerably higher in CD-1 mice (Manenti et al., 2003) than in rats (Poteracki and Walsh, 1998) ;
Based on these species differences, the postulated MOA for mouse lung tumor formation is assumed to be negligibly plausible in humans, with humans being expected to be substantially less sensitive than mice to all of the pulmonary effects of permethrin. Indeed, because permethrin did not produce any effects on Club cells or produce lung tumors in the rat, based on the proposed MOA in mice, it is highly unlikely that permethrin would produce lung tumors in humans (Table 13) . Furthermore, while electron microscopy or cell proliferation measurements were not conducted in dogs, light microscopic examination provided no effect of treatment on the dog lung in a 1-year study at doses up to 1000 mg/kg/d (JMPR, 1999) .
The available data demonstrate that isoniazid and permethrin produce mouse lung tumors by a similar mitogenic MOA. Epidemiologic evaluations of chemicals acting by this MOA have also been conducted. Isoniazid has been used since 1952 as a drug to treat tuberculosis. When isoniazid was administered to rats or mice throughout the life-span of the animals, it failed to induce lung tumors in rats, however, lung tumor incidences were increased in mice (Bhide et al., 1981; Menon and Bhide, 1983; Peacock and Peacock, 1966) . Isoniazid was also reported not to produce lung tumors in life-time studies in male and female Syrian hamsters (IARC, 1987) . Isoniazid is not considered to be a genotoxic agent (IARC, 1987) . Since available epidemiological data demonstrates that isoniazid is not carcinogenic to humans, isoniazid was classified into Group 3 (not classifiable as to its carcinogenicity to humans) by IARC (IARC, 1987) .
Like permethrin and isoniazid, flonicamid also failed to cause tumorigenic effects in a chronic rat feeding study (ECHA, 2012) . However, in mice a statistically significant increase in the incidence of lung bronchiolo-alveolar adenomas occurred in all 3 dose groups (30, 89, and 264 mg/kg/d) of both sexes. Lung carcinomas were only significantly increased in female mice given the highest dose level of flonicamid. Based on data from MOA experiments focusing on Club cell proliferation, the US.EPA concluded that lung tumors in CD-1 mice fed flonicamid are due to mitogenesis, a nonlinear, nongenotoxic MOA for which a threshold has been established (US. EPA, 2005) . However, the US.EPA classified flonicamid into the category "Suggestive evidence of carcinogenicity, but not sufficient to assess human carcinogenic potential" and the quantification of human cancer risk was not recommended (US. EPA, 2005) . Although the US.EPA could not dismiss human relevancy of carcinogenicity of flonicamid, it induced both lung adenomas and carcinomas whereas permethrin increased only lung adenomas. Furthermore, lung tumors were only induced in female mice by permethrin but were increased by flonicamid in both sexes of mice. These findings suggest that while both permethrin and flonicamid exhibit mitogenic effects on mouse Club cells, the potency of permethrin appears less than that of flonicamid. These differences need to be considered in the quantitative evaluation of the human relevance of permethrin-induced mouse lung tumors. Recently, the Committee for Risk Assessment at the European Chemical Agency (ECHA) concluded that based on strain and species differences in susceptibility, the lung tumors observed in mice are not relevant to humans and hence do not fulfill any criterion for Carcinogenic category 3 R40 or CLP category 2 H351 classification. ECHA concluded that no classification was required for flonicamid under either Directive 67/548/EEC or the CLP Regulation (ECHA, 2012 (ECHA, , 2013 .
Fluensulfone is a nematicide for agricultural use (Strupp et al., 2012 (Strupp et al., , 2016 , and chronic dietary exposure with fluensulfone led to bronchiolo-alveolar hyperplasia and bronchioloalveolar adenomas in CD-1 mice but not in rats. Genotoxicity could be excluded as a MOA. The MOA studies of fluensulfone identified Club cell proliferation as a key event, finally leading to adenoma formation in mice. Although electron microscopy was not evaluated at early time points of administration of fluensulfone (Strupp et al., 2012 (Strupp et al., , 2016 to completely exclude the possibility of cytotoxicity, there was no evidence of cytotoxicity, necrosis or inflammation by light microscopy at these early time points despite the presence of increased Club cell proliferation. Thus, it is most likely that the MOA for fluensulfone involved direct mitogenicity rather than cytotoxicity and consequent increased cell proliferation.
The available data demonstrate that permethrin, isoniazid, flonicamid, and fluensulfone share a similar mitogenic MOA for lung tumor formation in CD-1 mice, with some differences in potency. These chemicals also exhibit species differences in lung tumor formation, such that lung tumors develop in mice but not rats. As described earlier, there are marked species differences in lung physiology and biology between the mouse, rat, and human (Table 12) . Although the terminal bronchioles of Lumsden et al., 1984; McDowell et al., 1978; Plopper et al., 1980a; Smith et al., 1979; Strupp et al., 2016; US.EPA, 2005 . B: Carlson, 2008 Cruzan et al., 2009; Gervasi et al., 1991; Green et al., 1997 Green et al., , 2001a Lewis et al., 1994 Lewis et al., , 2009 Mattes and Mattes, 1992; Saghir et al., 2009; Vassallo et al., 2004 . C: Plopper et al., 1980a Smith et al., 1979 . D: Hahn et al., 2007 Travis et al., 2004 . E: Manenti et al., 2003 Poteracki and Walsh, 1998. mouse lung have high proportions of Club cells, rat lung contains a smaller proportion of Club cells, and human lung has lower proportions of Club cells than in rat lung (Lumsden et al., 1984; McDowell et al., 1978; Plopper et al., 1980a; Smith et al., 1979; Strupp et al., 2016; US.EPA, 2005) . A major factor in the susceptibility of the mouse to lung tumor formation by these chemicals is thus the species difference in lung Club cell abundance. The continued stimulation of cell proliferation may lead to tumor formation as a result of critical errors being produced during cell replication and/or to the enhanced proliferation of spontaneously initiated pre-neoplastic cells. Therefore, a greater proportion of Club cells per lung suggests a greater chance of developing lung tumors by compounds which target Club cells. Based on epidemiological data of permethrin (Rusiecki et al., 2009 ).
FIG. 3.
Human relevance of the mouse lung tumorigenic response of permethrin is evaluated based on the human relevance framework (Boobis et al., 2006 (Boobis et al., , 2008 Cohen et al., 2004; Meek et al., 2003; Sonich-Mullin et al., 2001 ).
Based on the species differences between the mouse, rat, and human in lung tumor formation and differences in lung physiology and biology, humans will be quantitatively much less sensitive than mice to permethrin and other agents that have a mitogenic effect on mouse lung Club cells (Figure 3 and Table 13 ).
In addition to a quantitative difference in response, a quantitative difference in exposure, which is not generally the basis for quantitative differences under the WHO/IPCS framework, is also discussed here. Permethrin produces lung tumors in female mice by a nongenotoxic MOA with a clear threshold for lung tumor formation. The lung tumors were observed in female mice at 2500 and 5000 ppm, with no lung tumors being observed at the only other much lower dose level of 20 ppm. The likely exposure of humans to permethrin is much lower than the doses required to produce morphologic, proliferation or tumorigenic effects in mouse lung. The ADI (Acceptable Daily Intake) for permethrin in humans is 0.05 mg/kg/body weight/d (WHO, 2009), which is a considerably lower dose level (less than approximately 7000 times) than the observed dose levels at which the mitogenic effects (365 mg/kg/d from these studies) or the tumorigenic effects (357 mg/kg/d from the bioassay) occur in the lung of female mice dosed at 2500 ppm (US. EPA, 2002) . Since the US.EPA estimated actual chronic exposure of the U.S. population as 0.000184 mg/kg/d (US.EPA, 2009), this provides a margin of approximately 1 900 000 relative to the effect levels in the mouse study. Thus, permethrin would not be expected to induce lung tumors in humans at realistic exposure levels. This conclusion is supported by epidemiological data for permethrin. The Agricultural Health Study evaluated the incidence of cancer among pesticide applicators exposed to permethrin and found no association between permethrin and all malignant neoplasms combined or for lung cancer specifically (Rusiecki et al., 2009) .
CONCLUSION: STATEMENT OF CONFIDENCE, ANALYSIS, AND IMPLICATIONS
Based on the data described earlier, a plausible MOA for permethrin-induced lung tumor formation in female mice has been developed, involving ultrastructural morphological changes, followed by a mitogenic effect resulting in Club cell proliferation, with prolonged administration producing Club cell hyperplasia and subsequently the formation of bronchioloalveolar adenomas. The proposed MOA for permethrin-induced mouse lung tumor formation is similar to that previously described for isoniazid, flonicamid, and fluensulfone. Although permethrin, isoniazid, flonicamid, and fluensulfone produce lung tumors in mice by a mitogenic MOA, these chemicals do not produce lung tumors in rats. Although the possibility that permethrin exposure may potentially result in enhancement of Club cell proliferation in humans cannot be completely excluded, there is sufficient information on differences in basic lung physiology and biology in the general literature to conclude that humans are quantitatively considerably less sensitive to agents that increase Club cell proliferation and lead to tumor formation in mice. The evidence strongly indicates that chemicals having such an effect in mice do not have this effect in rats and that humans share physiological similarities with rats. Thus, chemical exposures of this type are not likely to lead to an increase in susceptibility to lung tumor development in humans. In addition, the levels of exposure to permethrin in humans are considerably lower than those required to produce lung tumors in the sensitive species (mice, a margin of approximately 1 900 000). Therefore, it is reasonable to conclude that permethrin will not have any lung tumorigenic activity in humans. This conclusion is also supported by available epidemiological data where exposure of humans to permethrin does not result in any increase in lung tumors (Rusiecki et al., 2009) , similar to the lack of tumorigenic effect in patients treated with isoniazid (IARC, 1987) .
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